Thus, to test whether inhibition of LTCC activity might reduce PLN-induced arrhythmia phenotypes, we treated ACMs with a Ca2+ channel blocker, verapamil, and quantified the percentage of arrhythmic cells in response to PLN KD+co-culture with fibroblasts+isoproterenol treatment. This evidence concerns the gene PLN and Arrhythmia.